tykhr
sign in
free sign up
Tarsus Pharmaceuticals Inc
Biotechnology
Healthcare
TARS
39.35 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
55.35
52 week high
58.85
high
56.20
52 week low
0.00
low
54.21
growth
61.20 %
previous Close
55.63
P/E ratio
market cap
1.73 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
32.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top